Report overview
The global immunodiagnostics market is in the moderate growth stage. The integration of mature clinical chemistry analyzers and restricted specificity and sensitivity of immunoassays have generated demand for integrated immunochemistry analyzers. The increasing volume of tests conducted due to rise in laboratory consolidation has driven the trend of automated analyzers globally.
This report aims to provide a comprehensive presentation of the global market for Immunodiagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immunodiagnostics. This report contains market size and forecasts of Immunodiagnostics in global, including the following market information:
Global Immunodiagnostics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Immunodiagnostics market was valued at US$ 11420 million in 2022 and is projected to reach US$ 16670 million by 2029, at a CAGR of 5.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The increasing adoption of point-of-care testing (POCT) is expected to drive the growth prospects for the global immunodiagnostics market until the end of 2023. Some of the life-threatening conditions that need serious attention include sepsis and acute cardiac infarction. Such serious conditions with high mortality rate drive the necessity for POCT, which, in turn, boosts the demand for immunodiagnostics testing. One of the areas of focus for traditional and non-traditional healthcare companies are POCT for cardiovascular biomarkers. Also, POCT is fast, accurate, portable, and simple to interpret, which helps healthcare providers in alternative healthcare settings. Moreover, the cost of POCT is very low because of its small capillary tubes that need fewer reagents.
We surveyed the Immunodiagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Immunodiagnostics Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Immunodiagnostics Market Segment Percentages, by Type, 2022 (%)
Immunodiagnostic Instruments
Immunoassays
Global Immunodiagnostics Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Immunodiagnostics Market Segment Percentages, by Application, 2022 (%)
Oncology and Endocrinology
Hepatitis and Retrovirus Testing
Infectious Disease Testing
GI Stool Testing
Global Immunodiagnostics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Immunodiagnostics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Immunodiagnostics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Immunodiagnostics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
Danaher
Roche Diagnostics
F.Hoffmann-La Roche
Thermo Fisher Scientific
Johnson?Johnson
Siemens
Outline of Major Chapters:
Chapter 1: Introduces the definition of Immunodiagnostics, market overview.
Chapter 2: Global Immunodiagnostics market size in revenue.
Chapter 3: Detailed analysis of Immunodiagnostics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Immunodiagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
